Topics:

GSK socks $50M into venture fund backing biotech startups

Tools

GlaxoSmithKline ($GSK) put up $50 million of a $250 million life sciences fund, assembled by San Mateo, CA-based Sanderling Ventures, to help fill a geographic gap in their strategy to seed new biotech startups. Report

Filed Under